Market Closed -
Bombay S.E.
06:10:29 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
507.5
INR
|
-1.03%
|
|
+1.92%
|
-0.51%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
676.9
|
938.8
|
582.6
|
1,738
|
2,357
|
2,344
|
Enterprise Value (EV)
1 |
636.9
|
908.8
|
673.3
|
1,975
|
2,620
|
2,532
|
P/E ratio
|
10.9
x
|
12.7
x
|
5.64
x
|
-316
x
|
67
x
|
18.3
x
|
Yield
|
-
|
-
|
2.68%
|
-
|
0.33%
|
0.67%
|
Capitalization / Revenue
|
1.36
x
|
1.43
x
|
0.77
x
|
4.51
x
|
2.68
x
|
1.72
x
|
EV / Revenue
|
1.28
x
|
1.39
x
|
0.89
x
|
5.13
x
|
2.98
x
|
1.86
x
|
EV / EBITDA
|
7.06
x
|
9.28
x
|
4.29
x
|
267
x
|
19.6
x
|
9.55
x
|
EV / FCF
|
36.1
x
|
-11.2
x
|
-3.2
x
|
-17.8
x
|
-7.1
x
|
-102
x
|
FCF Yield
|
2.77%
|
-8.94%
|
-31.2%
|
-5.61%
|
-14.1%
|
-0.98%
|
Price to Book
|
2.07
x
|
2.35
x
|
1.11
x
|
3.35
x
|
4.24
x
|
3.45
x
|
Nbr of stocks (in thousands)
|
7,000
|
7,000
|
7,820
|
7,820
|
7,820
|
7,820
|
Reference price
2 |
96.70
|
134.1
|
74.50
|
222.2
|
301.4
|
299.7
|
Announcement Date
|
9/16/18
|
9/3/19
|
9/4/20
|
9/2/21
|
6/17/22
|
6/23/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
496.7
|
655.1
|
757.3
|
385
|
879.5
|
1,361
|
EBITDA
1 |
90.22
|
97.89
|
156.9
|
7.399
|
133.9
|
265.2
|
EBIT
1 |
83.01
|
89.67
|
142
|
-13.55
|
74.53
|
195.2
|
Operating Margin
|
16.71%
|
13.69%
|
18.75%
|
-3.52%
|
8.47%
|
14.34%
|
Earnings before Tax (EBT)
1 |
90.71
|
109.1
|
146
|
-10.64
|
49.55
|
178.6
|
Net income
1 |
64.57
|
82.61
|
103.4
|
-5.5
|
35.23
|
128.2
|
Net margin
|
13%
|
12.61%
|
13.65%
|
-1.43%
|
4.01%
|
9.42%
|
EPS
2 |
8.880
|
10.56
|
13.22
|
-0.7033
|
4.500
|
16.39
|
Free Cash Flow
1 |
17.66
|
-81.25
|
-210.3
|
-110.8
|
-369.1
|
-24.85
|
FCF margin
|
3.56%
|
-12.4%
|
-27.77%
|
-28.78%
|
-41.96%
|
-1.83%
|
FCF Conversion (EBITDA)
|
19.58%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
27.36%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
2.000
|
-
|
1.000
|
2.000
|
Announcement Date
|
9/16/18
|
9/3/19
|
9/4/20
|
9/2/21
|
6/17/22
|
6/23/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
90.7
|
237
|
262
|
188
|
Net Cash position
1 |
40.1
|
30
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
0.578
x
|
31.97
x
|
1.959
x
|
0.7083
x
|
Free Cash Flow
1 |
17.7
|
-81.2
|
-210
|
-111
|
-369
|
-24.9
|
ROE (net income / shareholders' equity)
|
22.9%
|
22.7%
|
22.4%
|
-1.06%
|
6.56%
|
20.2%
|
ROA (Net income/ Total Assets)
|
14.7%
|
12.6%
|
13.8%
|
-0.97%
|
4.77%
|
11.4%
|
Assets
1 |
440.7
|
655.5
|
750.1
|
569.6
|
739.1
|
1,124
|
Book Value Per Share
2 |
46.70
|
57.10
|
66.90
|
66.30
|
71.10
|
86.90
|
Cash Flow per Share
2 |
2.880
|
1.990
|
7.600
|
10.60
|
2.060
|
2.840
|
Capex
1 |
47.8
|
138
|
327
|
72.4
|
370
|
155
|
Capex / Sales
|
9.63%
|
21.14%
|
43.18%
|
18.8%
|
42.12%
|
11.37%
|
Announcement Date
|
9/16/18
|
9/3/19
|
9/4/20
|
9/2/21
|
6/17/22
|
6/23/23
|
|
1st Jan change
|
Capi.
|
---|
| -0.51% | 47.59M | | +5.14% | 103B | | -1.80% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.26B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|